Leading Article: Whose genes are we exploiting?

Related Topics
Twins are becoming big business. They are being studied by economists who are trying to work out how much influence education has upon employment prospects. Psychologists find them indispensable in the study of mental disorders such as schizophrenia. But where they are most useful and most lucrative is in the rapidly expanding industry of genetics.

The genes of identical twins are the resource base for the most effective studies designed to isolate nature from nurture, genetic influences from environmental factors. Yesterday more than a thousand twins gathered for a party hosted by doctors researching the genetic causes of a range of chronic diseases. The researchers are aiming for 5,000 participants. This could be a hugely valuable data bank.

Identical twins share 100 per cent of their genes. If they live apart it should be possible to work out whether any illnesses they suffer are the result of their lifestyles or their genetic inheritance. This in turn should help to develop cures.

The savings to the health service could be huge. Already researchers at St Thomas's hospital in London have identified genetic factors which might make women's bones more brittle in middle age, a condition known as osteoporosis. Two million people in the UK, 80 per cent of them women, suffer from osteoporosis. One in three women and one in 12 men have a fracture by the age of 70. The annual cost of the disease to the health service is estimated at pounds 750m.

The St Thomas's team wants to move on to study obesity, heart disease, high blood pressure and asthma. So the potential health benefits of this data bank may be vast. But so too might be the profits of the genetics companies which exploit the research. The rights to one gene that is thought to influence obesity were sold last year for $70m. The value of the St Thomas's data bank could run to hundreds of millions of pounds. The rights to exploit the data bank have been sold to a company called Gemini International, whose headquarters are in the British Virgin Islands.

To free-marketeers, the exploitation of such a gene data bank might not pose any troubling questions. Private-sector companies are taking a risk by investing in the research; they should reap the rewards. But this research is not quite like other pharmaceuticals research. Human beings are not just being used to test drugs; their living matter is being developed to help drugs. The ownership of the treatments developed by genetic research is hugely controversial.

But this is no simple story of private-sector exploitation, far from it. The St Thomas's team turned to private investment because they had to; public-sector grants had dried up. Several leading geneticists have left Britain in the past year because there is not enough money to fund their research; private finance is the only way to get their results into the international marketplace.

The issue of who owns the rights to genetic discoveries will not go away; it will become more pressing. A review of British legislation would be helpful but only up to a point: this is an international issue. Rulings by the International Court of Justice, the European Patent Convention or indeed the General Agreement on Tariffs and Trade are needed to help clear it up before the "gene prospectors" give the industry a bad name.

React Now

Latest stories from i100
Have you tried new the Independent Digital Edition apps?
iJobs Job Widget
iJobs General

Recruitment Genius: Finance Director

£65000 - £80000 per annum: Recruitment Genius: Finance Director required to jo...

Recruitment Genius: Medico-Legal Assistant

£15000 - £25000 per annum: Recruitment Genius: This is a unique opportunity fo...

Ashdown Group: (PHP / Python) - Global Media firm

£50000 per annum + 26 days holiday,pension: Ashdown Group: A highly successful...

The Jenrick Group: Quality Inspector

£27000 per annum + pension + holidays: The Jenrick Group: A Quality Technician...

Day In a Page

Read Next
David Cameron faces the press as he arrives in Brussels for the EU leaders summit on Thursday reuters  

On the Tusk of a dilemma: Cameron's latest EU renegotiation foe

Andrew Grice
John Profumo and his wife Valerie Robson in 1959  

Stephen Ward’s trial was disgraceful. There can be no justification for it

Geoffrey Robertson QC
Homeless Veterans appeal: 'You look for someone who's an inspiration and try to be like them'

Homeless Veterans appeal

In 2010, Sgt Gary Jamieson stepped on an IED in Afghanistan and lost his legs and an arm. He reveals what, and who, helped him to make a remarkable recovery
Could cannabis oil reverse the effects of cancer?

Could cannabis oil reverse effects of cancer?

As a film following six patients receiving the controversial treatment is released, Kate Hilpern uncovers a very slippery issue
The Interview movie review: You can't see Seth Rogen and James Franco's Kim Jong Un assassination film, but you can read about it here

The Interview movie review

You can't see Seth Rogen and James Franco's Kim Jong Un assassination film, but you can read about it here
Serial mania has propelled podcasts into the cultural mainstream

How podcasts became mainstream

People have consumed gripping armchair investigation Serial with a relish typically reserved for box-set binges
Jesus Christ has become an unlikely pin-up for hipster marketing companies

Jesus Christ has become an unlikely pin-up

Kevin Lee Light, aka "Jesus", is the newest client of creative agency Mother while rival agency Anomaly has launched Sexy Jesus, depicting the Messiah in a series of Athena-style poses
Rosetta space mission voted most important scientific breakthrough of 2014

A memorable year for science – if not for mice

The most important scientific breakthroughs of 2014
Christmas cocktails to make you merry: From eggnog to Brown Betty and Rum Bumpo

Christmas cocktails to make you merry

Mulled wine is an essential seasonal treat. But now drinkers are rediscovering other traditional festive tipples. Angela Clutton raises a glass to Christmas cocktails
5 best activity trackers

Fitness technology: 5 best activity trackers

Up the ante in your regimen and change the habits of a lifetime with this wearable tech
Paul Scholes column: It's a little-known fact, but I have played one of the seven dwarves

Paul Scholes column

It's a little-known fact, but I have played one of the seven dwarves
Fifa's travelling circus once again steals limelight from real stars

Fifa's travelling circus once again steals limelight from real stars

Club World Cup kicked into the long grass by the continued farce surrounding Blatter, Garcia, Russia and Qatar
Frank Warren column: 2014 – boxing is back and winning new fans

Frank Warren: Boxing is back and winning new fans

2014 proves it's now one of sport's biggest hitters again
Jeb Bush vs Hillary Clinton: The power dynamics of the two first families

Jeb Bush vs Hillary Clinton

Karen Tumulty explores the power dynamics of the two first families
Stockholm is rivalling Silicon Valley with a hotbed of technology start-ups

Stockholm is rivalling Silicon Valley

The Swedish capital is home to two of the most popular video games in the world, as well as thousands of technology start-ups worth hundreds of millions of pounds – and it's all happened since 2009
Did Japanese workers really get their symbols mixed up and display Santa on a crucifix?

Crucified Santa: Urban myth refuses to die

The story goes that Japanese store workers created a life-size effigy of a smiling "Father Kurisumasu" attached to a facsimile of Our Lord's final instrument of torture
Jennifer Saunders and Kate Moss join David Walliams on set for TV adaptation of The Boy in the Dress

The Boy in the Dress: On set with the stars

Walliams' story about a boy who goes to school in a dress will be shown this Christmas